GREAT AT SMALL THINGS

0

GeneCorner plasmid details

Last data update: 21 October 2021 10:13 CEST

Plasmid name: pDEST-Etag (LMBP 4540)

Add to cart

New search Print data sheet
Price category: Cat. 1 (cf. price list)
Status: GeneCorner core plasmid
GeneCorner sequence: p4540.gb (View with Genome Compiler)
p4540.txt
p4540.pdf
Sequence
analysis results
Genecorner:

-

Cloned DNA: B gene of the control of cell death locus of the Escherichia coli F plasmid (ccdB, lethal gene)
E-tag; N-terminal
Promoter: Simian cytomegalovirus immediate early promoter (CMV-IE) and enhancer
Phage T7 gene 10 promoter (T7g10)
Phage T3 promoter
Phage SP6 promoter
Escherichia coli lac operon promoter; mutant (lacUV5)
Ribosome
binding site:
-
Terminator: Simian virus 40 polyadenylation signal (SV40 polyA)
Selection marker: Ampicillin (amp)
Chloramphenicol (cam)
Replicon: Escherichia coli plasmid pMB1 origin
Phage f1 origin
Host range: Escherichia coli; use a ccdB-resistant strain for propagation
Mammalian cells
Avian cells
Parental clone: pCS2-ET
Further information: The plasmid was constructed by ligating the Gateway reading frame cassette C (rfC, from Invitrogen) into the StuI opened pCS2-ET vector. The XbaI site can be used to screen the orientation.
pDEST-Etag is a Gateway destination vector, containing the lethal B gene of the control of cell death locus of the Escherichia coli F plasmid (ccdB) flanked by the bacteriophage λ attR recombination sites.
pDEST-Etag is designed for fusing a gene of interest to the N-terminal E-tag according to the Gateway Cloning Technology (Invitrogen) and for high-level, constitutive, native expression of this gene in a wide variety of mammalian and avian cells under control of the strong simian cytomegalovirus immediate early promoter (CMV-IE) and enhancer.
A Gateway entry clone, containing the gene of interest flanked by the λ attL recombination sites, recombines with the attR sites of the destination vector, replacing the ccdB gene. Standard E. coli strains with the unreacted destination vector or with the by-product plasmid retaining the ccdB gene will fail to grow. Thus, this negative selection provides high-efficiency recovery of only the desired clones.
The chloramphenicol resistance gene located between the two attR sites permits counterselection.
This Gateway destination vector is compatible with the human orfeome library which is also available at BCCM/GeneCorner.
The nucleotide sequence of this plasmid corresponds with the EMBL Nucleotide Sequence Database accession number LT727253.1.
Other names of the plasmid are pdCS2-ET and pDEST-pCS2+ET.
EMBL Accession number: LT727253.1, view at EMBL, GenBank, DDBJ
Latest sequence update: 01/04/2003
Authenticity test: Restriction enzyme pattern analysed at GeneCorner: DraI, HincII, SmaI and XbaI.
Class: Recombinant plasmid
Type: Plasmid
History of deposit: This plasmid was deposited by Prof. Dr F. Van Roy(1) (2). It was constructed by B. Janssens(1) (2).
(1) Department for Molecular Biomedical Research, VIB, Ghent, Belgium
(2) Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
Plasmid reference: -
Related plasmid reference: Manual of Gateway Cloning Technology, Invitrogen
Restricted distribution: - BCCM MTA
Distributed as: H/P active culture or plasmid DNA
Host for distribution: Escherichia coli K12xB DB3.1
Host reference: -
Related host reference: Bernard et al., J. Mol. Biol. 226 (1992), 735-745 [PMID: 1324324]
Cultivation medium: LB-Lennox + ampicillin (100 μg/ml) + chloramphenicol (25 μg/ml)*
Cultivation temperature: 37°C
Biosafety level: L1
Cultivation remark: *: selection of transformants on chloramphenicol; subsequent cultivation of a single colony in liquid medium with ampicillin.
Other culture collection numbers: -

Refer in your Materials and Methods:

pDEST-Etag (LMBP 4540) is available at BCCM/GeneCorner. This plasmid was deposited by Prof. Dr F. Van Roy .

Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.

New search